
Rare Disease Genetic Testing Global Market Report 2025
Description
Rare Disease Genetic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on rare disease genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for rare disease genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare disease genetic testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Disease Type: Immunological Disorders; Cardiovascular Disorders; Neurological Disease; Endocrine And Metabolism Disorders Diseases; Hematological Diseases; Dermatological Disease; Other Disease Types
2) By Technology: Next-Generation Sequencing; Sanger Sequencing; Polymerase Chain Reaction Based Testing; Array Based Testing; Fluorescence In Situ Hybridization; Other Technologies
3) By Specialty: Molecular Genetic Tests; Chromosomal Genetic Tests; Biochemical Genetic Tests
4) By End-User: Hospitals And Clinics; Research Laboratories And Contract Research Organizations; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Immunological Disorders: Autoimmune Disorders; Allergic Conditions; Primary Immunodeficiency Disorders; Inflammatory Disorders
2) By Cardiovascular Disorders: Congenital Heart Defects; Cardiomyopathies; Aortic Aneurysms; Pulmonary Hypertension
3) By Neurological Disease: Neurodegenerative Disorders; Neuromuscular Disorders; Epileptic Syndromes; Movement Disorders
4) By Endocrine And Metabolism Disorders Diseases: Inherited Metabolic Disorders; Thyroid Disorders; Adrenal Disorders; Diabetes Related Genetic Conditions
5) By Hematological Diseases: Hemophilia; Thalassemia; Sickle Cell Disease; Clotting Disorders
6) By Dermatological Disease: Genetic Skin Disorders; Connective Tissue Disorders; Pigmentary Disorders; Keratinization Disorders
7) By Other Disease Types: Skeletal Dysplasia; Renal Genetic Disorders; Ophthalmic Genetic Conditions; Gastrointestinal Genetic Conditions
Companies Mentioned: Thermo Fisher Scientific Inc.; Quest Diagnostics Inc.; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Natera Inc.; OPKO Health Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; BioReference Laboratories Inc.; Invitae Corporation; Ambry Genetics Corporation; Centogene N.V.; Baylor Genetics Company; PreventionGenetics; Blueprint Genetics Oy; Realm IDX Inc.; Artemis DNA Inc.; BGI Genomics Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on rare disease genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for rare disease genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rare disease genetic testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Disease Type: Immunological Disorders; Cardiovascular Disorders; Neurological Disease; Endocrine And Metabolism Disorders Diseases; Hematological Diseases; Dermatological Disease; Other Disease Types
2) By Technology: Next-Generation Sequencing; Sanger Sequencing; Polymerase Chain Reaction Based Testing; Array Based Testing; Fluorescence In Situ Hybridization; Other Technologies
3) By Specialty: Molecular Genetic Tests; Chromosomal Genetic Tests; Biochemical Genetic Tests
4) By End-User: Hospitals And Clinics; Research Laboratories And Contract Research Organizations; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Immunological Disorders: Autoimmune Disorders; Allergic Conditions; Primary Immunodeficiency Disorders; Inflammatory Disorders
2) By Cardiovascular Disorders: Congenital Heart Defects; Cardiomyopathies; Aortic Aneurysms; Pulmonary Hypertension
3) By Neurological Disease: Neurodegenerative Disorders; Neuromuscular Disorders; Epileptic Syndromes; Movement Disorders
4) By Endocrine And Metabolism Disorders Diseases: Inherited Metabolic Disorders; Thyroid Disorders; Adrenal Disorders; Diabetes Related Genetic Conditions
5) By Hematological Diseases: Hemophilia; Thalassemia; Sickle Cell Disease; Clotting Disorders
6) By Dermatological Disease: Genetic Skin Disorders; Connective Tissue Disorders; Pigmentary Disorders; Keratinization Disorders
7) By Other Disease Types: Skeletal Dysplasia; Renal Genetic Disorders; Ophthalmic Genetic Conditions; Gastrointestinal Genetic Conditions
Companies Mentioned: Thermo Fisher Scientific Inc.; Quest Diagnostics Inc.; Eurofins Scientific SE; Agilent Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Natera Inc.; OPKO Health Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; BioReference Laboratories Inc.; Invitae Corporation; Ambry Genetics Corporation; Centogene N.V.; Baylor Genetics Company; PreventionGenetics; Blueprint Genetics Oy; Realm IDX Inc.; Artemis DNA Inc.; BGI Genomics Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. Rare Disease Genetic Testing Market Characteristics
- 3. Rare Disease Genetic Testing Market Trends And Strategies
- 4. Rare Disease Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global Rare Disease Genetic Testing Growth Analysis And Strategic Analysis Framework
- 5.1. Global Rare Disease Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global Rare Disease Genetic Testing Market Growth Rate Analysis
- 5.4. Global Rare Disease Genetic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global Rare Disease Genetic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global Rare Disease Genetic Testing Total Addressable Market (TAM)
- 6. Rare Disease Genetic Testing Market Segmentation
- 6.1. Global Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Immunological Disorders
- Cardiovascular Disorders
- Neurological Disease
- Endocrine And Metabolism Disorders Diseases
- Hematological Diseases
- Dermatological Disease
- Other Disease Types
- 6.2. Global Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Next-Generation Sequencing
- Sanger Sequencing
- Polymerase Chain Reaction Based Testing
- Array Based Testing
- Fluorescence In Situ Hybridization
- Other Technologies
- 6.3. Global Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Molecular Genetic Tests
- Chromosomal Genetic Tests
- Biochemical Genetic Tests
- 6.4. Global Rare Disease Genetic Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Research Laboratories And Contract Research Organizations
- Diagnostic Laboratories
- Other End Users
- 6.5. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Immunological Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Autoimmune Disorders
- Allergic Conditions
- Primary Immunodeficiency Disorders
- Inflammatory Disorders
- 6.6. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Cardiovascular Disorders, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Congenital Heart Defects
- Cardiomyopathies
- Aortic Aneurysms
- Pulmonary Hypertension
- 6.7. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Neurological Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neurodegenerative Disorders
- Neuromuscular Disorders
- Epileptic Syndromes
- Movement Disorders
- 6.8. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Neurological Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Neurodegenerative Disorders
- Neuromuscular Disorders
- Epileptic Syndromes
- Movement Disorders
- 6.9. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Endocrine And Metabolism Disorders Diseases, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Inherited Metabolic Disorders
- Thyroid Disorders
- Adrenal Disorders
- Diabetes Related Genetic Conditions
- 6.10. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Dermatological Disease, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic Skin Disorders
- Connective Tissue Disorders
- Pigmentary Disorders
- Keratinization Disorders
- 6.11. Global Rare Disease Genetic Testing Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Skeletal Dysplasias
- Renal Genetic Disorders
- Ophthalmic Genetic Conditions
- Gastrointestinal Genetic Conditions
- 7. Rare Disease Genetic Testing Market Regional And Country Analysis
- 7.1. Global Rare Disease Genetic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global Rare Disease Genetic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific Rare Disease Genetic Testing Market
- 8.1. Asia-Pacific Rare Disease Genetic Testing Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China Rare Disease Genetic Testing Market
- 9.1. China Rare Disease Genetic Testing Market Overview
- 9.2. China Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India Rare Disease Genetic Testing Market
- 10.1. India Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan Rare Disease Genetic Testing Market
- 11.1. Japan Rare Disease Genetic Testing Market Overview
- 11.2. Japan Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia Rare Disease Genetic Testing Market
- 12.1. Australia Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia Rare Disease Genetic Testing Market
- 13.1. Indonesia Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea Rare Disease Genetic Testing Market
- 14.1. South Korea Rare Disease Genetic Testing Market Overview
- 14.2. South Korea Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe Rare Disease Genetic Testing Market
- 15.1. Western Europe Rare Disease Genetic Testing Market Overview
- 15.2. Western Europe Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK Rare Disease Genetic Testing Market
- 16.1. UK Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany Rare Disease Genetic Testing Market
- 17.1. Germany Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France Rare Disease Genetic Testing Market
- 18.1. France Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy Rare Disease Genetic Testing Market
- 19.1. Italy Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain Rare Disease Genetic Testing Market
- 20.1. Spain Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe Rare Disease Genetic Testing Market
- 21.1. Eastern Europe Rare Disease Genetic Testing Market Overview
- 21.2. Eastern Europe Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia Rare Disease Genetic Testing Market
- 22.1. Russia Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America Rare Disease Genetic Testing Market
- 23.1. North America Rare Disease Genetic Testing Market Overview
- 23.2. North America Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA Rare Disease Genetic Testing Market
- 24.1. USA Rare Disease Genetic Testing Market Overview
- 24.2. USA Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada Rare Disease Genetic Testing Market
- 25.1. Canada Rare Disease Genetic Testing Market Overview
- 25.2. Canada Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America Rare Disease Genetic Testing Market
- 26.1. South America Rare Disease Genetic Testing Market Overview
- 26.2. South America Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil Rare Disease Genetic Testing Market
- 27.1. Brazil Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East Rare Disease Genetic Testing Market
- 28.1. Middle East Rare Disease Genetic Testing Market Overview
- 28.2. Middle East Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa Rare Disease Genetic Testing Market
- 29.1. Africa Rare Disease Genetic Testing Market Overview
- 29.2. Africa Rare Disease Genetic Testing Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa Rare Disease Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa Rare Disease Genetic Testing Market, Segmentation By Specialty, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. Rare Disease Genetic Testing Market Competitive Landscape And Company Profiles
- 30.1. Rare Disease Genetic Testing Market Competitive Landscape
- 30.2. Rare Disease Genetic Testing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Quest Diagnostics Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. Rare Disease Genetic Testing Market Other Major And Innovative Companies
- 31.1. QIAGEN N.V.
- 31.2. Natera Inc.
- 31.3. OPKO Health Inc.
- 31.4. Myriad Genetics Inc.
- 31.5. Fulgent Genetics Inc.
- 31.6. BioReference Laboratories Inc.
- 31.7. Invitae Corporation
- 31.8. Ambry Genetics Corporation
- 31.9. Centogene N.V.
- 31.10. Baylor Genetics Company
- 31.11. PreventionGenetics
- 31.12. Blueprint Genetics Oy
- 31.13. Realm IDX Inc.
- 31.14. Artemis DNA Inc.
- 31.15. BGI Genomics Co. Ltd.
- 32. Global Rare Disease Genetic Testing Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The Rare Disease Genetic Testing Market
- 34. Recent Developments In The Rare Disease Genetic Testing Market
- 35. Rare Disease Genetic Testing Market High Potential Countries, Segments and Strategies
- 35.1 Rare Disease Genetic Testing Market In 2029 - Countries Offering Most New Opportunities
- 35.2 Rare Disease Genetic Testing Market In 2029 - Segments Offering Most New Opportunities
- 35.3 Rare Disease Genetic Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.